The advent of microarray technology and the sequencing of the human genome
have enabled scientists to simultaneously interrogate the expression of thousands
of genes. These gene expression profiling studies have provided (i) a molecular
classification of breast cancer into clinically relevant subtypes, (ii) new tools to
predict disease recurrence and response to different treatments, and (iii) novel
insight into various oncogenic pathways and the process of metastatic progression.